Studentshare
Subjects
Miscellaneous
AstraZeneca Marketing Strategy: Challenges and Solutions

AstraZeneca Marketing Strategy: Challenges and Solutions - Essay Example

Add to wishlist

Summary

This study covers the global pharmaceutical industry, and more specifically AstraZenca, which is in a phase of restructuring and implementing operational issues. The pharmaceutical industry continued to grow through 2009, but the depressed stock markets reduced the market…

Download full paper File format: .doc, available for editing

GRAB THE BEST PAPER93.1% of users find it useful

AstraZeneca Marketing Strategy: Challenges and Solutions

Read Text Preview

Subject: Miscellaneous
Type: Essay
Level: Undergraduate
Pages: 46 (11500 words)
Downloads: 4
Author: kolbyluettgen

Extract of sample "AstraZeneca Marketing Strategy: Challenges and Solutions"

Download file to see previous pages

Thus, in a sense the industry is at the cross roads having consolidated its position in several respects, but also facing a number of new challenges, as new opportunities open up for the industry. (booz&co, 2009). AstraZenca, being one of the largest pharmaceutical companies in the world with a global presence, too is affected by the various environmental changes. Additionally, AstraZeneca has been burdened with overcapacity in manufacturing and product development and has been under pressure to downsize and make structural changes (Rosen, 2008).

The company has been on a spree of downsizing its jobs and has effected 3,000, job losses at its home country itself. The challenges faced by AstraZeneca also include its slow flow of new products on which it could have further enhanced its growth and also its various attractive patents reaching expiry within the next five years. Additionally, AstraZeneca has been looking for partners and buying out both R and D capabilities as well as expanding its marketing efforts. It collaborates with labs like Palatin Technologies and Arrow Therapeutics in a bid to boost its R and D and hence get more products in the market.

One particular move that AstraZeneca has made is to expand its manufacturing and marketing operations to the emerging markets especially in the Middle East. It has set up manufacturing units in the region as well as initiated its programs of active partnership with local governmental and non-governmental healthcare units. The current research therefore aims to assess the effectiveness of AstraZeneca’s marketing strategy for the Middle East. For doing this, the first step that the research undertakes is to collect data regarding the adopted strategy of AstraZeneca, its current and future plans for the region.

Next, the research includes a critical analysis of the marketing strategy of AstraZeneca with specific reference to the political, social, economic and legal environment of the region. For

...Download file to see next pages Read More

CHECK THESE SAMPLES OF AstraZeneca Marketing Strategy: Challenges and Solutions

Challenged Faced by Pharmaceutical Industry and Remedies by GlaxoSmithKline

Monitoring Payment: The growing challenges and the rising price pressure on the cost of development have limited the total revenue from the average drug.... The companies have to make sure that after the huge investment in the projects for marketing and development of new drugs is made, a considerable amount of control should be exercised on the revenue and profit streams....

8 Pages (2000 words) Case Study

Business Risks in the Pharmaceutical Industry based on AstraZeneca

Loss or expiration of patents, marketing exclusivity or trademarks negatively affects the company's pricing and sales.... For example, sales of best-selling drugs Losec/Prilosec, Zestril, and Nolvadex fell significantly in 2004 due to patent expiration (drugs developed by the company) and anticipated loss of marketing exclusivity (drugs developed by other laboratories but marketed by AstraZeneca).... Companies need to launch new drugs to replace those with expiring patents, marketing exclusivity or trademarks (Bate, 1997, p....

12 Pages (3000 words) Case Study

Business Organisation and Policy in Pharmaceutical Industry

Currently, there exists a definite and a well-defined pressure on firms to incessantly revitalize and transform themselves so as to stay innovative and competitive (Leonard-Barton 1995) and even during good times, firms are aligned with vacillating activities and pursuits… This is what is actually happening in the pharmaceutical industry, a sector well-known for its extreme reliance on applied research on diverse natural science disciplines (Koretz and Lee 1998). The industry in its present setting shows that competition has become Both large and small firms are confronted with huge demands to step up output but must stay creative and pioneering as they face mergers of immense scope, escalating health care costs, cost-control efforts, fast-changing population demographics and high-speed evolution of new technologies....

9 Pages (2250 words) Essay

Merger & Acquisition in Pharmaceutical Industry

This paper talks about the pharmaceutical sector trade literature which suggests many of the rationales for M&A cited in the academic literature, but also some others.... There is a clear sense from this literature that certain rationales are more adaptive and defensive in nature.... hellip; According to the report rationales reflect a more proactive and offensive thrust, such as diversification into new geographic markets and therapeutic areas, achieving scale and scope economies, developing competitive capabilities in R&D, and fostering disruptive change....

13 Pages (3250 words) Dissertation

Pfizers unsuccessful takeover of AstraZeneca

The bid was refused and it was only in April… This was achieved because Pfizer publicly announced its intentions amidst disinterest on the part of astrazeneca, which was forced into the negotiating table.... The bid price was increased to 63 billion and the pressure on AztraZeneca prompted the UK The Pfizer and astrazeneca Attempted Merger In the early part of high-level meetings were held between Pfizer and AztraZeneca for talks of a possible acquisition....

2 Pages (500 words) Essay

Pfizers Unsuccessful Takeover of Astrazeneca

However, the success of merger or acquisition bid is often met by unprecedented challenges that may be unforeseen for the interested organization.... his essay describes the example Pfizer's Unsuccessful Takeover of astrazeneca of a failed merger due to the unwillingness of the management to accept the takeover.... On 25th November 2013, Pfizer, a US company expressed its interest to enter into a merger with astrazeneca.... After considering the offer, the astrazeneca rejected the offer and the no more discussion was held after January....

12 Pages (3000 words) Essay

GlaxoSmithKline Company Overview and Need for Strategy

The major need for a competitive strategy at GSK can largely be said to be based on an ever increasing global competitiveness which has always made the company a 4th force in terms of market share and market capital.... This need is what has informed the use of a peculiar strategy that seeks to make the company competitive and set it apart from its major competitors.... An important area of the strategy has been the need for the company to become economically sustainable....

16 Pages (4000 words) Essay

Analysis of Financial Performance of Bristol-Myers Squibb

The declared business operations of the company, as indicated in its report to the Securities and Exchange Commission (SEC), is “the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products.... The "Financial Performance of Bristol-Myers Squibb" paper is being undertaken in the nature of a company study from the point of view of a potential investor, on Bristol-Myers Squibb Company, and its prospects in the industry for the coming year....

12 Pages (3000 words) Case Study